Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
about
Immunotherapy for tuberculosis: future prospectsMethods and clinical development of adenovirus-vectored vaccines against mucosal pathogensTuberculosis vaccines and prevention of infectionPrime-boost approaches to tuberculosis vaccine developmentProtection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in CattleTargeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacyPreclinical evidence for implementing a prime-boost vaccine strategy for tuberculosisSimultaneous immunization against tuberculosisProduction of adenovirus vectors and their use as a delivery system for influenza vaccines.Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.The TB pandemic: an old problem seeking new solutions.Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine ModelToward novel vaccines against tuberculosis: current hopes and obstacles.Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analysesCD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infectionSimultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosisChemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85AMultifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in miceEfficient generation of mucosal and systemic antigen-specific CD8+ T-cell responses following pulmonary DNA immunization.Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression.Vaccine against tuberculosis: what's new?Development of vaccines against burkholderia pseudomallei.The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosisCharacterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous RoutesGoats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85AOrgan distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vectorCombined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus.Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1
P2860
Q26741261-6905F318-B6AE-44F6-933D-E409A67FFAD4Q26750912-679284AF-EC3F-47F1-9373-4DF69702BA22Q26782022-83D2A103-EA6F-4A50-B9BD-ADE57C5335FFQ27024526-4E869357-3DBB-4422-85C9-3137718BA9E9Q27346370-7311942E-3ECA-4CEF-AD68-296930D0F11CQ28354371-1386DF0F-6AA1-4C1F-93F4-A2644C40E37CQ28730427-8C7E5592-96E0-4E25-9463-891A26124B46Q28742666-74B9E272-1A27-44C5-8472-D6A34071BB57Q30226988-C3D6F54C-032B-45EA-9FB9-D0F2B8F4BB31Q30279061-EBC1F7A1-762C-4BA8-96DF-79ADFB069C0CQ30360726-2B6A4086-1E48-4541-84EF-F18E9513629DQ30375962-63F2A177-3F18-43AF-87D3-AEB8DFB03500Q30484783-ABBC360D-19BF-49BF-A92E-5FC86A46AD37Q31015281-C7F99002-7F2D-44A3-B24B-6A81615909D0Q31156691-2EACC310-B623-41A0-81C8-A1912EE1E588Q33428562-E3F9230B-DDCE-4FC3-B0B6-F998D79DFD79Q33466022-F7711359-2954-4004-B6E5-57A4B744955DQ33518452-CF1A652F-3772-468D-830D-64762D533F85Q33694896-2F5C4153-6642-4E91-A1EA-1B3F99AAA14AQ33713700-F9AC2FD2-39FF-42E3-98D0-B580908066E9Q33717592-FEDC48C9-6E7A-416A-8B77-4608E9F2FC2CQ33839055-C826EF17-1429-468B-BFED-716F5AAF9C1FQ33877287-23B53213-6AFB-46E4-AFD2-48E950BD7C28Q33992101-4E6411AE-4171-4910-998F-6AA7F94A7000Q34053500-45D79AB6-F91C-4F85-9040-219D96DF63ADQ34259027-ECE84C95-B6BE-4AE9-AA02-2F1456E200B8Q34531535-D21B2F22-9E26-47B1-99D4-7C73AF1E1CBBQ34726923-FD05394F-7800-4ABC-9DB5-ADD11F75723AQ35054007-C213EF97-1834-4337-9D3D-6DBA37E93982Q35101472-624EAD91-3992-4F54-A8A0-EA616762709AQ35234118-28AE2C98-60F6-4749-BE96-78072E8BA9F6Q35689134-715C1688-F84F-42BB-980E-78FFEF700F55Q35887146-33CFB466-5864-411D-8324-63BDC7515179Q35896225-B6852D55-206C-4718-8734-8693C09C96D5Q36002296-10D4EAEB-3702-40A3-A20B-89ACB988615AQ36191665-A86908D2-5CA8-470C-A7CD-F1328138176CQ36369598-557AFA7B-8CE2-4A91-A7F6-D6AB3B530EB4Q36485052-C34740E6-BB13-4416-9197-B695539F420CQ36527796-B79BDD06-EBFB-45EF-9648-4F6B99657D90Q36539553-4F1B3873-41B6-46B1-B42C-FE9F83999F39
P2860
Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@ast
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@en
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@nl
type
label
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@ast
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@en
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@nl
prefLabel
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@ast
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@en
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@nl
P2093
P2860
P921
P356
P1476
Intranasal boosting with an ad ...... gainst pulmonary tuberculosis.
@en
P2093
Anna Zganiacz
Michael Santosuosso
Sarah McCormick
Xizhong Zhang
P2860
P304
P356
10.1128/IAI.00517-06
P407
P577
2006-08-01T00:00:00Z